|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4800 AUD | -5.88% |
|
-6.80% | -26.15% |
| Market Cap | 139M 97.36M 84.94M 78.31M 73.67M 138M 9.17B 933M 361M 4.52B 365M 357M 15.7B | P/E 2026 * |
-6.76x | P/E 2027 * | -4.42x |
|---|---|---|---|---|---|
| Enterprise Value | 147M 103M 89.92M 82.9M 77.99M 146M 9.71B 987M 383M 4.78B 386M 378M 16.63B | EV / Sales 2026 * |
19.1x | EV / Sales 2027 * | 19.4x |
| Free-Float |
57.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.88% | ||
| 1 week | -6.80% | ||
| Current month | -12.73% | ||
| 3 months | +2.13% | ||
| 6 months | -21.31% | ||
| Current year | -26.15% |
| 1 week | 0.48 |  | 0.51 |
| 1 month | 0.47 | | 0.59 |
| Current year | 0.42 | | 0.73 |
| 1 year | 0.28 | | 0.73 |
| 3 years | 0.28 | | 0.78 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-24 | Expiration | Chief Executive Officer | 2,250,000 | 0.7781% | ||
| 14/10/25 | Expiration | Chief Executive Officer | 745,962 | 0.3217% | ||
| 21/11/24 | Buy | Chief Technology Officer | 1,600,000 | 0.6900% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.88% | -6.80% | +47.69% | -12.73% | 104M | |
| -1.21% | -3.33% | +38.84% | +145.38% | 992B | |
| -2.48% | -4.23% | +49.88% | +39.07% | 564B | |
| -2.14% | -3.76% | +16.72% | +56.15% | 391B | |
| -1.18% | +0.68% | +24.66% | +16.53% | 330B | |
| -2.36% | -2.30% | +23.37% | +11.59% | 280B | |
| -2.45% | -0.84% | +23.51% | +30.06% | 279B | |
| -1.91% | -1.06% | -42.60% | -49.25% | 196B | |
| -1.19% | -0.04% | +16.39% | +47.00% | 184B | |
| -1.35% | +1.88% | +14.59% | +56.94% | 156B | |
| Average | -1.73% | +0.27% | +21.31% | +34.07% | 337.13B | |
| Weighted average by Cap. | -0.98% | -0.49% | +27.10% | +63.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.68M 5.38M 4.7M 4.33M 4.07M 7.61M 507M 51.57M 19.98M 250M 20.18M 19.75M 868M | 8.86M 6.22M 5.42M 5M 4.7M 8.78M 586M 59.54M 23.07M 288M 23.3M 22.8M 1B |
| Net income | -20.45M -14.34M -12.51M -11.53M -10.85M -20.26M -1.35B -137M -53.23M -666M -53.77M -52.62M -2.31B | -30.9M -21.67M -18.91M -17.43M -16.4M -30.62M -2.04B -208M -80.45M -1.01B -81.26M -79.52M -3.5B |
| Net Debt | 8.15M 5.72M 4.99M 4.6M 4.33M 8.08M 539M 54.76M 21.22M 265M 21.43M 20.97M 922M | 33.53M 23.52M 20.52M 18.92M 17.79M 33.23M 2.22B 225M 87.3M 1.09B 88.18M 86.29M 3.79B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 0.4800 $ | -5.88% | 149,531 |
| 17/06/26 | 0.5100 $ | +3.03% | 59,596 |
| 16/06/26 | 0.4950 $ | -1.98% | 81,561 |
| 15/06/26 | 0.5050 $ | +1.00% | 4,797 |
| 12/06/26 | 0.5000 $ | +2.04% | 85,743 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
